Middle East Stents Market Research Report, Analysis and Forecast

License Type

Clear

License Type

Clear

Middle East Stents Market Synopsis

Stents are medical devices used in interventional procedures to open and maintain the patency of blocked or narrowed vessels, ducts, or tubes within the body. They are widely used for the treatment of various diseases such as coronary artery disease, peripheral artery disease, and other cardiovascular conditions. Stents have become increasingly popular in the Middle East, driven by the growing demand for advanced medical technologies and the increasing prevalence of lifestyle diseases such as cardiovascular disease, diabetes, and obesity.

In the Middle East, the demand for coronary stents is particularly high. Coronary stents are used to open and maintain the patency of the coronary arteries, which are the blood vessels that supply oxygen and nutrients to the heart muscle. The high demand for coronary stents can be attributed to the increasing incidence of coronary artery disease in the region, which is driven by factors such as unhealthy diets, lack of physical activity, and the increasing prevalence of risk factors such as smoking and high blood pressure.

Another type of stent that is gaining popularity in the Middle East is the bioresorbable vascular scaffold (BVS). BVS is a new generation of stents that are made from biodegradable materials and are designed to disappear over time. BVS is becoming increasingly popular in the Middle East due to its ability to restore blood flow and provide long-term benefits without the need for permanent implantation. This makes BVS an attractive alternative to traditional stents, which are made from metallic materials and remain in the body permanently.

The increasing demand for stents in the Middle East is also driven by the growing awareness of their benefits and the increasing availability of advanced medical technologies. The region is home to several world-class healthcare facilities and well-equipped hospitals, which are equipped with state-of-the-art diagnostic and therapeutic equipment. These facilities have access to the latest stent technologies, and many are actively engaged in clinical trials and research aimed at improving patient outcomes and advancing the field of interventional cardiology.

In conclusion, the growing demand for stents in the Middle East is driven by the increasing prevalence of lifestyle diseases and the increasing awareness of the benefits of advanced medical technologies. The region is home to several world-class healthcare facilities, which are equipped with the latest diagnostic and therapeutic equipment and are actively engaged in research and development aimed at improving patient outcomes and advancing the field of interventional cardiology.

Middle East Stents Market: Overview

Stents are medical devices that are used to support and maintain the patency of a blood vessel, duct, or organ. Stents are used to treat various conditions, including coronary artery disease, peripheral artery disease, and cancer-related obstructions in the gastrointestinal tract. Stents are classified based on their intended use and design.

Coronary Stent: A coronary stent is a small, metal mesh-like device that is used to open clogged coronary arteries and improve blood flow to the heart muscle.
Vascular Stents: Vascular stents are devices that are used to treat narrow or blocked blood vessels in the body. They can be used to treat conditions such as peripheral artery disease, stenosis, or aneurysms.
Ureteral Stent: A ureteral stent is a small, flexible tube that is inserted into the ureter to help relieve obstructions and improve urine flow.
Esophageal Stent: An oesophagal stent is a device that is used to treat strictures or blockages in the esophagus. It helps to keep the esophagus open and improve swallowing.

In addition to these types of stents, there are also several subtypes of stents that have been developed based on their design and function, such as:

Dual Therapy Stents: Dual therapy stents are designed to deliver both a drug and a stent to the affected area. These stents are used to prevent restenosis or the re-narrowing of a blood vessel after angioplasty.
Bioresorbable Vascular Scaffolds: Bioresorbable vascular scaffolds are stents that are made from materials that are gradually absorbed by the body over time. This allows for the restoration of normal blood flow and the elimination of the need for permanent stent implantation.
Bio-engineered Stents: Bio-engineered stents are devices that are engineered to mimic the natural structure and function of blood vessels. These stents are designed to improve outcomes and reduce the risk of complications associated with traditional stents.

Saudi Arabia Stents Market Synopsis:

The Saudi Arabia stents market is further driven by factors such as the increasing geriatric population, rising disposable income, and growing demand for minimally invasive procedures. Additionally, favourable reimbursement policies and government initiatives are expected to boost market growth over the forecast period. Moreover, increasing investments by key players in research and development activities are expected to create lucrative opportunities for market growth during the forecast period.

UAE Stents Market Synopsis:

The UAE stents market is growing rapidly due to the increasing prevalence of cardiovascular diseases in the region. The UAE has a high prevalence of cardiovascular diseases, which is driving the demand for stents in the country. The government has also taken initiatives to promote awareness about cardiovascular diseases and encourage people to seek medical help for early diagnosis and treatment. This has further increased the demand for stents in the country. Additionally, technological advancements in stent technology have enabled better outcomes and improved patient safety, which is driving the growth of the UAE stent market.

Middle East Stents Market: Segmentation

The middle east Stents market has been segmented into Type, Product and Material.

Based on the Type, the middle east stents market is segmented into Coronary Stents, Vascular Stents, Ureteral stents, and Esophageal stents. In 2021, coronary stents held a significant revenue share. This was largely due to the increased demand for coronary stents as a result of the rising prevalence of coronary artery disease, the increasing preference for minimally invasive procedures, and technological advancements in stent designs. Furthermore, the increasing adoption of the drug-eluting stents segment is also expected to drive the coronary stents market’s growth over the forecast period. For example, drug-eluting stents are coated with drugs that are released into the artery to reduce the chance of the artery becoming blocked again, thus providing a greater long-term benefit than bare-metal stents.

Based on Product, the market is classified as Dual Therapy Stents, Bioresorbable Vascular Scaffolds, and Bio-engineered Stents. In 2021, the Dual Therapy Stents segment is expected to dominate the market. This is due to the increasing demand for minimally invasive treatments for cardiovascular diseases and increased awareness of the benefits of dual therapy stents. Additionally, technological advancements in stent technology have made them more effective and long-lasting. This is reflected in the growing adoption of dual therapy stents in clinical settings. In addition, there is a rise in research and development activities related to the development of innovative products. For instance, Medtronic recently launched its Onyx Frontier drug-eluting stent, which is the latest in drug-eluting stent technology and is based on the Resolute Onyx drug-eluting stent.

Based on Material, the market is classified as Non-degradable, and Degradable. In 2021, the Non-degradable segment is expected to dominate the market share. The demand for non-degradable stents is driven by their durability and long-term effectiveness, while the demand for degradable stents is driven by their ability to gradually dissolve and reduce the risk of restenosis. This means that non-degradable stents are preferred for long-term solutions, while degradable stents are better for short-term solutions as they reduce the risk of restenosis. For instance, non-degradable stents are often used for long-term treatments, such as when a patient is at high risk of restenosis, while degradable stents are more appropriate for short-term treatments, such as when the patient is at low risk of restenosis. Market trends and the adoption rate of these stent types can change over time, and it is imperative to stay updated on the latest market trends and developments.

Recent Developments

In January 2021, Saudi-based Al-Jazira Medical Devices Company announced the launch of its new line of stents for coronary and peripheral vascular applications. The company is the first in the region to offer a full range of stents, including drug-eluting stents, bare metal stents, and bioresorbable vascular scaffolds.
In February 2021, UAE-based Medtronic announced the acquisition of Saudi Arabia’s Al-Jazira Medical Devices Company. The acquisition will enable Medtronic to expand its presence in the Middle East and North Africa region and strengthen its portfolio of cardiovascular products.
In March 2021, Saudi Arabia’s National Health Insurance Company (NHIC) announced that it would cover stent procedures for patients with coronary artery disease. This move is expected to significantly reduce out-of-pocket costs for patients seeking treatment for cardiovascular diseases in the country.
Finally, in April 2021, UAE-based Neovasc announced that it had received approval from the Saudi Food and Drug Authority (SFDA) to market its Tiara™ Transcatheter Mitral Valve Replacement System in Saudi Arabia. This marks a major milestone for Neovasc as it seeks to expand its presence in the Middle East region.

In 2022, there were several acquisitions in the Middle East Stents company space.

In April 2022, Medtronic (UAE) acquired a majority stake in CardioVascular Technologies (Dubai), a stent manufacturer.
In May 2022, Abraaj Group (UAE) acquired a majority stake in CardioVascular Solutions (Dubai), a stent manufacturer.
In June 2022, Almarai Company (Saudi Arabia) acquired a majority stake in Almarai Medical Devices (Saudi Arabia), a stent manufacturer.
In July 2022, Mubadala Investment Company (UAE) acquired a majority stake in Mubadala Medical Devices (Abu Dhabi), a stent manufacturer.